NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease
- PMID: 37735992
- PMCID: PMC11017435
- DOI: 10.1111/cns.14476
NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease
Abstract
Aims: The aim of this review is to systematically summarize and analyze the noncoding RNAs (ncRNAs), especially microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), in the cell apoptosis among Alzheimer's disease (AD) in recent years to demonstrate their value in the diagnosis and treatment of AD.
Methods: We systematically summarized in vitro and in vivo studies focusing on the ncRNAs in the regulation of cell apoptosis among AD in PubMed, ScienceDirect, and Google Scholar.
Results: We discover three patterns of ncRNAs (including 'miRNA-mRNA', 'lncRNA-miRNA-mRNA', and 'circRNA-miRNA-mRNA') form the ncRNA-based regulatory networks in regulating cell apoptosis in AD.
Conclusions: This review provides a future diagnosis and treatment strategy for AD patients based on ncRNAs.
Keywords: AD; NcRNAs; cell apoptosis; regulatory network.
© 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures





Similar articles
-
Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics.Metab Brain Dis. 2025 Jan 4;40(1):84. doi: 10.1007/s11011-024-01520-7. Metab Brain Dis. 2025. PMID: 39754674 Free PMC article. Review.
-
Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer's Disease.Protein Pept Lett. 2024;31(11):862-883. doi: 10.2174/0109298665335550241011080252. Protein Pept Lett. 2024. PMID: 39558496 Review.
-
Noncoding RNA crosstalk in brain health and diseases.Neurochem Int. 2021 Oct;149:105139. doi: 10.1016/j.neuint.2021.105139. Epub 2021 Jul 16. Neurochem Int. 2021. PMID: 34280469 Free PMC article. Review.
-
Identification of a lncRNA/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease.J Integr Neurosci. 2023 Oct 17;22(6):136. doi: 10.31083/j.jin2206136. J Integr Neurosci. 2023. PMID: 38176923
-
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.Front Immunol. 2022 Jun 2;13:908076. doi: 10.3389/fimmu.2022.908076. eCollection 2022. Front Immunol. 2022. PMID: 35720333 Free PMC article. Review.
Cited by
-
Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications.Inflammopharmacology. 2025 Apr;33(4):1785-1802. doi: 10.1007/s10787-025-01715-z. Epub 2025 Mar 15. Inflammopharmacology. 2025. PMID: 40088370 Review.
-
Advancements in multi-omics research to address challenges in Alzheimer's disease: a systems biology approach utilizing molecular biomarkers and innovative strategies.Front Aging Neurosci. 2025 Jul 23;17:1591796. doi: 10.3389/fnagi.2025.1591796. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40771197 Free PMC article. Review.
-
Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics.Metab Brain Dis. 2025 Jan 4;40(1):84. doi: 10.1007/s11011-024-01520-7. Metab Brain Dis. 2025. PMID: 39754674 Free PMC article. Review.
-
Non-coding RNAs involved in the molecular pathology of Alzheimer's disease: a systematic review.Front Neurosci. 2024 Jun 28;18:1421675. doi: 10.3389/fnins.2024.1421675. eCollection 2024. Front Neurosci. 2024. PMID: 39005845 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical